en: About 18 percent of men taking finasteride developed prostate cancer , compared with 24 percent on placebo . They found that 6.4 percent of men on finasteride had high-grade tumors , compared to 5.1 percent taking a placebo .
ms: Kira-kira 18 peratus lelaki yang mengambil finasteride mengembangkan kanser prostat, berbanding dengan 24 peratus pada plasebo. Mereka mendapati bahawa 6.4 peratus lelaki pada finasteride mempunyai tumor gred tinggi, berbanding 5.1 peratus mengambil plasebo.